Genmab launches “AI Everywhere”

• • Genmab expanded ChatGPT Enterprise licenses to over 2,000 employees.


• • The initiative aims to accelerate scientific research and document workflows.


• • The company relies on OpenAI for data security and privacy controls.

Context
Genmab is a biotechnology firm specializing in antibody therapies. They are moving from a limited pilot program to a companywide AI integration.

Christian Perspective
The use of AI in biotechnology must be scrutinized to ensure it does not facilitate the subversion of natural biological realities. Scientific advancement should serve to heal the body without crossing into the realm of playing God through genetic manipulation. We must ensure these tools are used to uphold the sanctity of life rather than redefine it.

Implications
The rapid adoption of AI in biotech could accelerate the development of technologies that challenge traditional views on gender and biological sex. This shift risks further decoupling human identity from its divinely ordained, immutable biological foundations. It presents a challenge to the natural order by potentially making the manipulation of human biology more efficient and widespread.

Broader Trends
This reflects a globalist push toward total technological integration in every sector of the economy. As AI becomes ubiquitous, it serves as a tool for centralized control and the erosion of individual agency. Such trends often align with the broader cultural movement toward replacing traditional human structures with algorithmic governance.

Takeaway
Christian leaders and citizens must demand transparency in how AI influences biological research and ethics. We must prioritize technologies that protect the nuclear family and biological integrity over those that promote secularist ideologies. Maintaining a firm grip on biological truth is essential as these digital tools become more pervasive.